Scientists at the Israel Institute of Biological Research (IIBR) in Ness Ziona have made a significant breakthrough in the development of a vaccine against coronavirus.
We are talking about the isolation of a monoclonal antibody from one reconstructed cell, which can attack the virus and neutralize it in the patient's body.
According to the publication, the stage of development of the antibody formula has already passed. In the near future it will be patented and the search for an international manufacturer that can mass-produce the drug will begin.
On the eve of May 4, an international donor online conference was convened on the initiative of the European Union, during which it was possible to raise € 7.4 billion for the development of a vaccine against coronavirus, reported iz.ru.